Previous close | 67.93 |
Open | 68.14 |
Bid | 68.08 x 50000 |
Ask | 68.18 x 50000 |
Day's range | 68.14 - 68.51 |
52-week range | 66.76 - 104.22 |
Volume | |
Avg. volume | 54 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 02 May 2023 - 08 May 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
CVS Health® (NYSE: CVS) today announced it expects to complete its acquisition of Signify Health (NYSE: SGFY) on or around March 29, 2023, subject to the satisfaction or waiver of the remaining customary closing conditions set forth in the merger agreement.
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Wall Street has become pretty pessimistic on the broader market's near-term growth prospects. Consensus estimates call for just 4% earnings growth for the S&P 500 in 2023. Growth could trail the S&P 500's historical average of 10% for longer than that if we enter a recession.